Innovative Blood Testing Tech Could Spell the End of Needle Phobia - Digital Health Technology News

London, UK – April 10th, 2025 – UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at least 1 in 10 adults. This health tech collaboration aims to make blood testing accessible and pain-free for individuals who experience an intense fear of needles by using a non-invasive, needle-free method. Needle phobia often deters people from seeking essential medical care, including preventative health measures. It is estimated that 10% of adults avoid vaccinations or medical procedures due to this reason, a decision that can have long-term health consequences. Regular preventative health screenings, including blood tests, are crucial for the early detection of potential health issues and proactive health management. Research by the British Medical Association indicates that 40% of the uptake of health services in England may be preventable by tackling the

London, UK – April 10th, 2025 – UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at least 1 in 10 adults. This health tech collaboration aims to make blood testing accessible and pain-free for individuals who experience an intense fear of needles by using a non-invasive, needle-free method. Needle phobia often deters people from seeking essential medical care, including preventative health measures. It is estimated that 10% of adults avoid vaccination